arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

Bausch & Lomb Corp

BLCO
$16.82 ▼ -0.25 (-1.49%) at close
Industrials ·Ophthalmic Goods ·USOphthalmic Goods
24 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
34
Health
Poor
Bearish
auto_awesome

Analytical Summary

Bausch & Lomb Corp faces fundamental challenges with weakness in Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $6.0B
Dividend Yield —
Revenue Growth 9.1% ↘
Op. Margin 6.0% ↗
ROIC 0.7% ↗
FCF / Share $0.23 ↗
Trailing P/E —
Price / Book 0.9x
FCF Yield 1.4%
Debt / Equity 0.80
info Valuation on last close. End-of-day price, Sep 24, 2026.

24-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$1.39B
↑ +9.1% —
Net Income Profit after all expenses
$-14.00M
↑ +77.4% —
Operating Margin Operating profit as % of sales
6.0%
↑ +124.5% 34th
FCF / Share Free cash flow per share
$0.23
↑ +219.9% —
Long-Term Debt Long-term obligations
$5.08B
↑ +0.8% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↓
25
Returns
38
Financial Health ↓
43
Cash Quality ↓
29

bar_chart Data from SEC EDGAR XBRL filings

Synced 2 days ago 7 years · 24 quarters